- Clinical Technology
- Adult Immunization
- Hepatology
- Pediatric Immunization
- Screening
- Psychiatry
- Allergy
- Women's Health
- Cardiology
- Pediatrics
- Dermatology
- Endocrinology
- Pain Management
- Gastroenterology
- Infectious Disease
- Obesity Medicine
- Rheumatology
- Nephrology
- Neurology
- Pulmonology
Direct-Acting Antivirals Not Linked to Liver Cancer Recurrence
Results of the largest study of its kind may help quell longstanding controversy surrounding the impact of DAA therapy on recurrence of HCC.
In an effort to help clarify ongoing controversy surrounding the effects of direct-acting antiviral (DAA) therapies for hepatitis C virus (HCV) infection on hepatocellular carcinoma (HCC) recurrence, researchers led by Amit G. Singal, MD, MS, conducted the largest study of its kind comparing HCC recurrence patterns between DAA-treated patients vs untreated patients across multiple clinical centers in the US and Canada. What did the study reveal? And how will the results impact clinical practice? Find out with our quick slideshow below.Â
No Rx Required for COVID-19 Vaccination But ACIP Calls for Better Informed Consent Process
September 22nd 2025The ACIP on September 19 narrowly voted against requiring a prescription to get the shot but urged more detailed discussion of vaccine risks during shared decision making conversations.
